Page 859 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

Index 837

Rhabdomyoma, characteristics of, 140 Sarcoma (Continued) Short-T1 Inversion Recovery (STIR),
117–118, 119f
Rhabdomyosarcoma, 405t injection-site, 418–425 Signal transduction
malignant, 608
characteristics of, 140
VetBooks.ir immunohistochemical markers/panels for, metallic implants and, 17 cancer and, 257
pathology and natural behavior of, 456
72t–73t
protein kinase effect on, 42
Rickard strain of FeLV (FeLV-R), 23 therapy and prognosis for, 459–460 protein kinase role in, 257–258
Risk ratio (RR), 86 Scapulectomy, for bone tumors, 541 Signal transduction inhibitor, 182
RNA-containing virus, 19 SCC. see Squamous cell carcinoma Signet-ring cell, 134f
RNA seq, 154 Schwannoma tumor, 138 Silver stain, 71t
RNA tumor virus (retrovirus), 41 Scintigraphy, 118 Silver staining of nucleolar organizer regions
Robenacoxib, 293t–294t Scirrhous response, 63 (AgNOR), 71
Rocky Mountain spotted fever, 633f extracellular matrix and, 136 Simply laser therapy (LT), 336
Romidepsin, 270 Scraping, of specimen, 127 Single-agent carboplatin chemotherapy, for
RON. see Recepteur d’origine Nantaise Scrotal tumor canine osteosarcoma, 542
ROS. see Reactive oxygen species canine, 636–637 Single-agent doxorubicin chemotherapy, for
Round cell tumor, cell characteristics in, feline, 637 canine osteosarcoma, 542
132–141 Sebaceous adenoma, 133f Single-based mutation, 148
RQ. see Respiratory quotient Sebaceous epithelioma, 359 Single nucleotide polymorphism (SNP), study
RT. see Radiation therapy Sebaceous gland carcinoma, 359 of, 347
RTK. see Receptor tyrosine kinase Sebaceous gland tumor, 132–133 Single-photon emission computed
Rummel tourniquets, for adrenal tumors, 574 Sebaceous or meibomian gland adenomas, tomography/positron emission
Rural environment, 15–16 675 tomography (SPECT/PET), 119–121
Russell bodies, 142 Second opinion, 75 Sinonasal cancer, 92
Secondary uveal neoplasms, 682–683 Sinus, tumors of, 494–503
S Secondhand smoke, lung cancer and, 14 Size, of biopsy sample, 61
S. typhimurium, 236 Seed and soil hypothesis, 54 Skeletal muscle, tumors of, 408
S phase, 182 Selegiline, for canine pituitary-dependent rhabdomyosarcoma, 408, 409f
G 1 /G 2 phase and, 210 hypercortisolism, 567 Skeletal system, tumors of, 524–564
SAE. see Serious adverse event Selenium, 309 Skin cancer
Saline, for specimen collection, 127 Seminoma genetic abnormalities in, 354
Salivary gland neoplasia, 448 characteristics of, 627t immunosuppression and, 353–354
comparative aspects of, 449 hormone levels in, 628–629 ionizing radiation and thermal
diagnostic techniques for, 448 metastasis of, 629, 629f injury, 352
history and clinical signs of, 448 pathology and pathogenesis of, 627 sunlight/ultraviolet irradiation and, 16
incidence and risk factors for, 448 VEGF and MVD, 628 Skin tumor, 352–366
pathology of, 448 view of, 628f–629f biopsy of, 355
prognosis of, 449 Sensitization, of pain, 290 classification of, 354
therapy for, 448–449 Sentinel lymph node, 168 diagnostic techniques/workup of, 355
Salivary gland tumor, 133 mapping, 161 etiology of, 352–354
Salmonella, VNP20009 and, 236 biopsy and, 161–162 history/clinical signs of, 355
Salvage therapy, 183 Sequencing, in polymerase chain incidence of, 352
Samarium, 297–298 reaction, 148 in cats, 353t
153 Samarium ethylenediamine-tetramethylene Serious adverse event (SAE), 344 in dogs, 353t
phosphonate ( 153 Sm-EDTMP), 540 Serratia marcescens, 236 staging of, 355
Samarium Sm153 lexidronam, 297–298 Sertoli cell tumor surgery for, 355
Sanctuary sit, 52f characteristics of, 627t tumor grading for, 355
Sanguinarine, 333 CT image of, 627f Skull tumor, computed tomography,
Sarcoma, 63 hormone levels in, 628–629 3D-reconstructed image of, 116f
bacterial infections and, 236 metastasis of, 629 Slide preparation, 129
epithelial-to-mesenchymal transition role pathology and pathogenesis of, 627 153 Sm, 547–548
in, 7 Serum alkaline phosphatase, in canine Small cell lung carcinoma, 146
feline, 418–425 osteosarcoma, 532–533, 532f Small-gauge needle, 127
histiocytic, 792t, 794–797 Set-up margin, 215–216 Small intestine, surgery for, 465–466, 466f
diagnosis and staging, 795–796, Sex cord stromal tumors Small molecule inhibitor, 262
795f–796f in cats, 598 function of, 262
genetics and biologic behavior, 794–795, history and clinical signs of, 598–599 types of
795f in dogs, 597–598 imatinib as, 262
hemophagocytic, 792t, 797 histology and metastatic sites for, sunitinib (Sutent), 262
history and clinical signs, 795 597–598 vemurafenib (Zelboraf) as, 262
treatment and prognosis, 796–797 patterns for, 598 for veterinary medicine, 262
immunohistochemical markers/panels for, Sex hormone, cancer and exposure to, 92 Small molecule TKI, 392
72t–73t Shipping, of biopsy sample, 61 153 Sm-EDTMP, 547–548